Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Gene Therapy to Target CD19 for Hematological Tumors by Chengdu USino Technology Biology for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
Gene Therapy to Target CD19 for Hematological Tumors is under clinical development by Chengdu USino Technology Biology and currently in...
Data Insights
Gene Therapy to Target CD19 for Hematological Tumors by Chengdu USino Technology Biology for Hematological Tumor: Likelihood of Approval
Gene Therapy to Target CD19 for Hematological Tumors is under clinical development by Chengdu USino Technology Biology and currently in...